deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT01462630

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma

Sponsor: Fox Chase Cancer Center

Conditions Adult Angiosarcoma Recurrent Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma
Interventions computed tomography fludeoxyglucose F 18 laboratory biomarker analysis pazopanib hydrochloride positron emission tomography
Updated 10 times since 2017 Last updated: Jul 26, 2022 Started: Nov 3, 2011 Primary completion: Jan 2, 2019 Completion: Jan 12, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Adult Angiosarcoma and Recurrent Adult Soft Tissue Sarcoma, this trial is completed. The trial is conducted by Fox Chase Cancer Center and has accumulated 10 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotRecruiting~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshotActive Not Recruiting~Dec 2019 – ~Jul 2020 · 7 months · monthly snapshotActive Not Recruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshotActive Not Recruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jan 2021 — Sep 2022 [monthly]

    Active Not Recruiting PHASE2

  5. Jul 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

▶ Show 5 earlier versions

  1. Dec 2019 — Jul 2020 [monthly]

    Active Not Recruiting PHASE2

  2. Aug 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Jun 2018 — Aug 2019 [monthly]

    Recruiting PHASE2

  4. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fox Chase Cancer Center
  • National Cancer Institute (NCI)
Data source: Fox Chase Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations